(Q43542169)

24 November 2017

title

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population (English)

1 reference

24 November 2017

1 reference

9

1 reference

24 November 2017

12

1 reference

24 November 2017

5

Lisa A Jackson

1 reference

24 November 2017

11

Eric Weintraub

1 reference

24 November 2017

8

Roger Baxter

1 reference

24 November 2017

Hung Fu Tseng

1

1 reference

24 November 2017

Lina S Sy

2

1 reference

24 November 2017

Lei Qian

3

1 reference

24 November 2017

S Michael Marcy

4

1 reference

24 November 2017

Jason Glanz

6

1 reference

24 November 2017

Jim Nordin

7

1 reference

24 November 2017

James Donahue

10

1 reference

24 November 2017

Vaccine Safety Datalink (VSD) Team

13

1 reference

24 November 2017

language of work or name

English

0 references

publication date

28 November 2012

1 reference

Clinical Infectious Diseases

24 November 2017

published in

1 reference

24 November 2017

volume

56

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

315-321

1 reference

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Transmission of Bordetella pertussis to young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

The methodology of self-controlled case series studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Tutorial in biostatistics: the self-controlled case series method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

The Vaccine Safety Datalink: a model for monitoring immunization safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Injection site and risk of medically attended local reactions to acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS871

21 January 2018

Identifiers

DOI

10.1093/CID/CIS871

1 reference

24 November 2017

1 reference